Washington Law Blog
Personal Injury, Car Accidents, Trucking Accidents,
motorcycle accidents and consumer law blog...

  • * First Name:
  • * Last Name:
  • * Email:
  • * Phone Number:
  • Comment:
  • Accept Terms *
  • *Denotes Required Field

Law Blog Categories

Car Accidents
3 Reasons to Hire Phillips Webster

Our attorneys have decades of experience negotiating with insurance companies regarding all types of vehicle accidents. If you have been injured in a wreck, contact us today.

  1. We represent EVERYONE in need anywhere in Washington - Minor and Major Injuries
  2. Experienced trial attorneys that will fight for your right to recover compensation
  3. FREE Case Review and we only get paid if you get paid
Learn more about our:
Seattle Car Accident Lawyers

Verdicts & Settlements

$20 MILLION - Commercial Injury
Confidential settlement for a commercial injury case

$19  Million - Grant of Coverage
Grant of coverage in insurance coverage case

$2 MILLION - INSURANCE BAD FAITH
Settlement in insurance bad faith case

$1.5 MILLION - CAR ACCIDENT WRONGFUL DEATH
Vancouver, Washington car accident that resulted in a death

$1 MILLION - DUI ACCIDENT VICTIM
Settlement for young man hit by a drunk driver

Our jury trial experience shows in the results we get both inside and outside of the courtroom.

More Verdicts and Settlements

 

Posts Tagged ‘Zicam’

The Dangers of Anosmia – Why the Zicam Issue Matters

anosmia, defective drugs attorneys, depression, FDA, gas leaks, injuries, loss of sense of smell, recall, side effects, Zicam

June 18th, 2009: Washington Law Blogger

When people hear about products being recalled and the FDA warning the public to stop using them because of a link to serious side effects, most would assume those side effects are more severe than the loss of the sense of smell. Anosmia, as it’s known in medical circles, is a condition that’s been diagnosed more than 130 times in consumers who had used certain Zicam products, and as a result it’s no longer available in retail outlets around the country.

We’ve been posting about the details of the issues involving Zicam lately, but some are wondering why anosmia is something to be concerned with, when other products have been known to cause cancer and death. However, basic research will tell anyone that the loss of the sense of smell, particularly if it’s permanent, can be a dangerous condition for several reasons.

When someone cannot smell, the most obvious danger it creates is that those people may not be able to sense dangers that include smoke from a fire or poisonous substances or gas leaks. However, there are other problems associated with anosmia, and they are directly correlated with the longer duration of this condition.

Those who cannot smell will often fall into a depression, as they understand that they are physically limited and are also concerned about their lack of ability to detect the dangers described above. Medical experts have also noted that those with anosmia will slowly lose weight as a result of a loss of appetite, and this can create many other medical problems that are high-risk in nature.

Ultimately, anosmia is a serious enough side effect that the FDA ordered the makers of Zicam to stop marketing the product and for Matrixx Initiatives, Inc., the manufacturer, to voluntarily pull the products from the shelves. If you or someone you love has been injured as a result of using Zicam, contact the defective drugs lawyers at Phillips & Webster today to schedule a free initial consultation.

Zicam Removed from Retail Shelves

ansomia, attorneys, FDA, injuries, Matrixx Initiatives, recall, side effects, warning, Zicam

June 17th, 2009: Washington Law Blogger

Yesterday, we alerted our readers to the fact that the US Food and Drug Administration (FDA) had issued a public warning regarding the dangers associated with several Zicam products. The agency also delivered a letter to Matrixx Initiatives, Inc. stating that they had to stop marketing these products unless they decided to put them through the normal FDA approval process that’s required of other medications.

Today, Matrixx Initiatives, Inc. responded by voluntarily pulling the products in question from retail shelves across the United States until the matter is resolved. The three specific products within the overall product line that were pulled include:

  • Zicam Cold Remedy Nasal Gel (15mL, NDC 62750-003-10)
  • Zicam Cold Remedy Swabs (20 swabs, NDC 67250-003-20)
  • Zicam Cold Remedy Swabs, Kids Size (20 swabs, NDC 67250-003-21)

To reiterate the warning issued by the FDA yesterday, you should immediately stop using these products if you have them in your home.

The reason this issue arose is because the FDA received at least 130 reports of consumers using the Zicam products listed above and developing ansomia, which is the loss of the sense of smell. Consumers reported the development of this side effect soon after use, and while no duration of the condition has been defined, some reported that it took several months for their sense of smell to return.

It’s believed that zinc, one of the ingredients in Zicam products, was the reason for this side effect, as it has been known to create similar problems in people who have been exposed to it in the past. If you or someone you love has been harmed as a result of using Zicam, contact the defective drugs attorneys at Phillips & Webster immediately to schedule a free initial consultation.

Zicam Comes Under Fire From FDA

anosmia, attorneys, Defective Drugs, FDA, injuries, loss of smell, Matrixx Initiatives, US Food and Drug Administration, warning letter, Zicam

June 16th, 2009: Washington Law Blogger

Matrixx Initiatives is a company that manufactures, markets and distributes a product line known as Zicam, which is an over-the-counter product sold to help with the symptoms of the common cold. It’s sold in several forms, including nasal spray and swabs, and at least partially as a result of Zicam’s success, Matrixx Initiatives’ stock price has risen and held steady even in the current marketplace.

However, negative news hit the wire today as the US Food and Drug Administration announced that it has sent a letter to Matrixx Initiatives instructing it to stop marketing Zicam unless the company decides to file an application for a drug approval with the agency to continue to market these products. If the company does so, Zicam will be subject to the same testing and analytical standards as any other medication.

The reason for this letter is that the FDA received at least 130 reports of consumers using Zicam products and developing a condition known in medical circles as anosmia, which is the loss of the sense of smell. Some consumers reported this side effect after only one use, and no duration for this side effect has yet been established. Therefore, the FDA is demanding a closer look at the product and the presence of one ingredient in particular, zinc, which has been linked to this side effect in other contexts.

There were three Zicam products subject to the FDA’s letter:

  • Zicam Cold Remedy Nasal Gel (15mL, NDC 62750-003-10)
  • Zicam Cold Remedy Swabs (20 swabs, NDC 67250-003-20)
  • Zicam Cold Remedy Swabs, Kids Size (20 swabs, NDC 67250-003-21)

If you are currently using Zicam products, the FDA advises you to stop doing so. If you or someone you love has been injured as a result of using these products, contact the defective drugs lawyers at Phillips & Webster today to schedule a free initial consultation.